Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated (NYSE: TDG) files a variety of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its aerospace components business, capital structure and governance. This page compiles TransDigm’s SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to locate annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically describe TransDigm’s business segments, risk factors, product categories and financial results. For this company, filings often discuss its role as a designer, producer and supplier of highly engineered aircraft components, its organization into segments such as power and control and airframes, and its use of acquisitions and financial leverage as part of its strategy, as reflected in the Polygon description and company disclosures.
Current reports on Form 8-K are particularly important for tracking material events at TransDigm. Recent 8-K filings describe acquisitions such as the Simmonds Precision Products business and a definitive agreement to acquire Stellant Systems, debt offerings and amendments to the company’s credit agreement, special cash dividends funded with new debt and changes in executive leadership and board composition. These documents provide timely details on transactions, financing terms and governance decisions.
This page also offers access to filings related to debt instruments and credit agreements, where TransDigm outlines terms for senior secured notes, senior subordinated notes and term loans, as well as any amendments that reprice or extend these facilities. Where available, insider transaction reports on Form 4 and proxy statements on Schedule 14A can shed light on executive and director share ownership and compensation structures.
Stock Titan’s platform enhances these filings with AI-generated highlights and explanations, helping users quickly identify key sections, understand complex capital structure language and see how new 8-K events connect to prior disclosures. Real-time updates from EDGAR ensure that new TransDigm filings appear promptly, while the AI layer reduces the time needed to parse lengthy documents and track the regulatory record for TDG.
MCCULLOUGH GARY E reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group Inc. director Gary E. McCullough received 37 shares of common stock as a stock-based director fee. The shares were valued at $1,214.66 per share, reflecting payment of a semi-annual board fee in stock rather than cash under the Director Share Plan. Following this award, he directly holds 952 common shares, indicating a relatively small, routine compensation-related increase in his ownership rather than an open-market purchase.
Santana Michele reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group INC director Michele Santana received 30 shares of Common Stock as a compensation award. The shares were valued at $1,214.66 each and were issued in lieu of a semi-annual director cash fee, based on fair market value under the company’s Director Share Plan. After this grant, Santana directly holds 771 TransDigm shares, reflecting routine equity-based board compensation rather than an open-market purchase.
BARR DAVID reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group director David Barr received 41 shares of Common Stock as a grant. The shares were valued at $1,214.66 per share and were issued on March 20, 2026. After this award, Barr directly owns 32,179 shares. A footnote explains the shares were received in lieu of a semi-annual director fee, based on fair market value under the company’s Director Share Plan.
Graff Michael reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group director Michael Graff received 30 shares of Common Stock as a stock grant on March 20, 2026. The shares were valued at $1,214.66 per share and were issued in lieu of his semi-annual director fee under the company’s Director Share Plan. Following this grant, he holds 1,683 shares directly, plus additional indirect holdings held by family trusts for the benefit of his children.
Howley W Nicholas reported acquisition or exercise transactions in this Form 4 filing.
TransDigm Group director W. Nicholas Howley received 113 shares of Common Stock as a grant on March 20, 2026. The shares were issued at a fair market value of $1,214.66 per share, in lieu of a semi-annual director fee under the Director Share Plan.
After this award, Howley holds 113 shares directly. He also has indirect beneficial holdings of 8,262 shares through The Howley Family Foundation and 21,547.513 shares through the W. Nicholas Howley Family Trust u/a/d 4/23/99, as reported in this filing.
TransDigm Group director W. Nicholas Howley, through the W. Nicholas Howley Family Trust, reported an option exercise and related share sales. The trust exercised stock options for 10,132 shares of TransDigm common stock at an exercise price of $50.9200 per share, converting them into 10,132 common shares.
The trust then sold 10,132 common shares in multiple open-market transactions on the same date at prices ranging from about $1,205.4151 to $1,231.3415 per share. Following these transactions, the trust continues to hold 21,547.513 TransDigm common shares indirectly attributed to Howley.
TransDigm Group’s Co‑Chief Operating Officer Joel Reiss exercised stock options and then sold shares in the open market. He exercised options for 3,900 shares of common stock at an exercise price of $284.97 per share and acquired the underlying shares.
On the same date, he sold 3,900 common shares in a series of transactions at prices around $1,222.87 to $1,250.65 per share, leaving him with 3,600 common shares held directly. Following the option exercise, he also continues to hold 27,500 stock options scheduled to expire on November 8, 2027. This filing reflects a routine exercise‑and‑sell transaction by a senior executive rather than a change in company operations.
TransDigm Group Incorporated reported the results of its 2026 Annual Meeting of Stockholders. Stockholders elected ten directors, including Jane M. Cronin, Michele L. Santana, and Robert J. Small, with each nominee receiving substantially more votes "for" than "withheld" and with broker non-votes recorded.
Stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with 51,593,887 votes for, 1,227,313 against and 12,544 abstentions. In an advisory vote, stockholders approved the compensation of the company’s named executive officers, with 48,583,255 votes for, 1,612,610 against, 20,962 abstentions and 2,616,917 broker non-votes. No other matters were submitted for a vote.
TransDigm Group Inc director Robert J. Small reported an indirect open‑market purchase by Stockbridge Fund, L.P. of 1 share of common stock at $1,285.00 per share on February 25, 2026. The filing notes this purchase was matchable under Section 16(b) with a prior sale of 1 share at $1,335.72 per share by an entity in which he has a pecuniary interest, and he paid the issuer the difference between the two prices. Following the transactions reported, indirect holdings include 366,142 shares held by Stockbridge Fund, L.P., 68,139 shares held by Stockbridge Partners LLC, and 60,246 shares held by certain family trusts, plus 5,625 shares held directly.
TransDigm Group’s Co-Chief Operating Officer Patrick Joseph Murphy exercised stock options and acquired common shares. On February 24, 2026, he exercised options for 1,160 shares and 300 shares of TransDigm common stock.
The 1,160 shares were acquired at $269.42 per share and the 300 shares at $347.17 per share through derivative exercises coded as “M.” Following these transactions, Murphy directly owned 2,515 shares of TransDigm common stock.